MedPath

A randomized controlled pilot study comparing the efficacy of topical coal tar to topical corticosteroids in children aged 1 to < 16 years with moderate-severe atopic dermatitis.

Phase 4
Completed
Conditions
Atopic dermatitis
atopic eczema
10014982
Registration Number
NL-OMON42910
Lead Sponsor
Radboud Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

- Male or female patients aged between 1 and <16 years of age
- Diagnosis of AD based on the criteria of Hanifin and Rajka
- Moderate to severe AD based on EASI score >7.1

Exclusion Criteria

- Hypersensitivity and/or intolerance to topical corticosteroids or topical coal tar
- Indication for systemic therapy or a medical need to use a higher level of topical corticosteroids than moderate potency topical corticosteroids

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome is the percentage change in EASI score at week 2. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcomes: percentage change in EASI score at week 4, EASI-75 at week<br /><br>2 and week 4, Pruritus VAS, Patient Oriented Eczema Measure (POEM), Patient<br /><br>Global Assessment of Disease Severity (PGA), Health-related Quality of Life<br /><br>(CDLQI), Family impact of childhood Atopic Dermatitis (DFI), number of<br /><br>(treatment-related) adverse events, FLG mutation status, NMF amount in stratum<br /><br>corneum and skin microbiota composition.</p><br>
© Copyright 2025. All Rights Reserved by MedPath